ReviewFuture oncology (London, England)2018

Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.

Smita S Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.